Role of Low-Dose Infliximab for Inflammatory Complications of Central Nervous System Tuberculosis: A Retrospective Cohort Study
Clinical Infectious Diseases · 20.05.2026 · 82 (5) · 852-856
DOI: 10.1093/cid/ciaf573 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 20.03.2026. Verfasst von Selwyn Selva Kumar D und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Christian Medical College, Vellore, Tamil Nadu, India. Hauptthemen laut MEDLINE: Infliximab, Tuberculosis, Central Nervous System, Antitubercular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
We evaluated low-dose infliximab (5 mg/kg) as adjunctive therapy in 20 patients with severe central nervous system tuberculosis. At 3 months, 60% achieved disability-free survival (modified Rankin Scale ≤ 2), and 75% showed clinically meaningful improvement. Our outcomes matched reports of high-dose infliximab. Randomized trials to optimize dosing are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Christian Medical College, Vellore, Tamil Nadu, India.
- Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India.
- Department of Neurology, Christian Medical College, Vellore, Tamil Nadu, India.
- Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
ORCID-Profile: Nishi Somarkutty, Veerasamy Nagaraj, Rajiv Karthik, Harshad Arvind Vanjare, Prabhakar Thirumal Appaswamy, George M Varghese
Zitieren
APA
Kumar D, S. S., Somarkutty, N., Prasad D, J. H., Gautam, P., Nagaraj, V., Karthik, R., Vanjare, H. A., Appaswamy, P. T., Michael, J. S., Varghese, G. M., & Manesh, A. (2026). Role of Low-Dose Infliximab for Inflammatory Complications of Central Nervous System Tuberculosis: A Retrospective Cohort Study. Clinical Infectious Diseases, 82(5), 852-856. https://doi.org/10.1093/cid/ciaf573
Vancouver
Kumar D SS, Somarkutty N, Prasad D JH, Gautam P, Nagaraj V, Karthik R, et al. Role of Low-Dose Infliximab for Inflammatory Complications of Central Nervous System Tuberculosis: A Retrospective Cohort Study. Clinical Infectious Diseases. 2026;82(5):852-856. doi:10.1093/cid/ciaf573
BibTeX
@article{KumarD2026,
author = {Kumar D, Selwyn Selva and Somarkutty, Nishi and Prasad D, Jayavelu Hariram and Gautam, Priyanka and Nagaraj, Veerasamy and Karthik, Rajiv and Vanjare, Harshad Arvind and Appaswamy, Prabhakar Thirumal and Michael, Joy Sarojini and Varghese, George M and Manesh, Abi},
title = {Role of Low-Dose Infliximab for Inflammatory Complications of Central Nervous System Tuberculosis: A Retrospective Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {5},
pages = {852--856},
doi = {10.1093/cid/ciaf573}
}
EUVIMED